Combined inhibition of IL-6 and IL-8 pathways suppresses ovarian cancer cell viability and migration and tumor growth

Ovarian cancer is the most lethal gynecological cancer type in the United States. The success of current chemotherapies is limited by chemoresistance and side effects. Targeted therapy is a promising future direction for cancer therapy. In the present study, the efficacy of co-targeting IL-6 and IL-...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ruijie, Roque, Dana M., Reader, Jocelyn, Lin, Jiayuh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973967/
https://www.ncbi.nlm.nih.gov/pubmed/35315502
http://dx.doi.org/10.3892/ijo.2022.5340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973967/
https://www.ncbi.nlm.nih.gov/pubmed/35315502
http://dx.doi.org/10.3892/ijo.2022.5340

Ejemplares similares